Disclosed is an oral mucosa delivery system that allows a composition housed therein to be dispensed in different amount and/or for different duration. The delivery system may comprise a spray cap or an aerosol cap capable of controlling the delivery duration and/or amount by a mechanical or electronic means.

A device for delivering a predetermined amount of at least one substance to a body orifice of a subject includes a) a container for containing said at least one substance; b) a delivery end for placement in proximity to the orifice, the delivery end being in fluid communication with the container; c) a valve mechanically connectable to said container, characterized by at least two configurations: (i) an ACTIVE CONFIGURATION in which said valve enables delivery of predetermined amount of said substance from said container to said body orifice via said delivery end; and, (ii) an INACTIVE CONFIGURATION, in which said valve prevents delivery of said predetermined amount of said substance from said container to said body orifice; d) a trigger mechanism adapted to reconfigure said valve from said INACTIVE CONFIGURATION to said ACTIVE CONFIGURATION, and vice versa; and e) a fluid tight chamber.

Provided is pharmaceutical composition for intranasal delivery, wherein the pharmaceutical composition includes a therapeutically active ingredient including a CGRP inhibitor. Also provided is a method for delivering a CGRP inhibitor to a subject, wherein the method includes intranasally administering to the subject a composition including a therapeutically active component including a CGRP inhibitor.

The present invention comprises a compact atomizer that substantially encapsulates a standard inhalant canister and allows for in-line dispensing through a mouthpiece formed in an actuating cover. The compact atomizer comprises an actuating cover and housing that cooperate to secure the canister. By compressing the actuating cover and housing together, a nozzle of the canister is depressed to release a portion of substance within the canister. Compression is enabled by an actuation surface formed in the actuating cover. Substance is released in-line with the canister through a mouthpiece at the end of the actuating cover. The result is a small, compact, yet attractive atomizer that can be carried in a pocket or the like while keeping the canister free of debris.

Provided herein are dry powder formulations comprising epinephrine alone or in combination with at least one enabling agent suitable for nasal application. Also provided are unit dose forms and devices comprising such formulations and methods of using such formulations for the treatment of various conditions including anaphylaxis, anaphylactoid reaction, respiratory conditions, hemodynamic collapse, and for administration during cardiopulmonary arrest and other life-threatening conditions.

Provided herein are drug products adapted for nasal delivery comprising a device and a pharmaceutical composition comprising an opioid receptor antagonist or unit doses thereof, pharmaceutical compositions comprising an opioid receptor antagonist, and methods of use and preparation thereof.

A spray device includes a mouthpiece that accommodates a spray nozzle unit. The spray nozzle unit is operatively connected to a liquid reservoir to receive a pressurized liquid to be sprayed. A connection between the spray nozzle unit and the liquid reservoir is effected by a flexible tube that connects at one end substantially fixedly to the mouth piece in fluid communication with the spray nozzle device. The liquid reservoir is interchangeably coupled to the opposite end of the flexible tube and, preferably, comprises a standard syringe. A spray delivery device comprises a holder for holding the syringe and has at least one manipulator member that is configured to impose an enhanced force on the plunger.

In general, systems for administering a dmg are provided. In an exemplary embodiment, a dmg administration system includes a dmg administration device configured to communicate with a computer system and at least one sensor configured to obtain sensor data and communicate the sensor data to the drug administration device. The dmg administration device is configured to utilize a first drug dosing scheme when a drug is delivered to a patient, determine a second drug dosing scheme for delivering a drug to the patient dependent on dosing data from the computer system and sensor data collected by the sensor during and/or after the delivery of the first drug according to the first drug dosing scheme, and utilize the second drug dosing scheme when the drug is delivered to the patient.

An atomizer device comprises a container (20) with a liquid chamber (21) for receiving a liquid for atomizing and a spray nozzle (50) which is able and configured to form a mist from the liquid under an increased operating pressure. The liquid chamber (21) is closed by a plunger (22) which is received movably therein and is able and configured to expel during an axial displacement at least a part of the liquid from the liquid chamber. Provided between the plunger (22) and the spray nozzle (50) is an air bubble barrier (80) which is at least substantially unbridgeable to possible air bubbles in the liquid, but which comprises a passage (85) for the purpose of allowing at least substantially free passage of the liquid. In a method for preparing such a container it is subjected to a centrifuging step in order to expel possibly enclosed air upstream of the barrier device as far as possible.

A syringe-shaped spraying device includes: a syringe-shaped spraying device main body including a barrel that stores a liquid medicine, a plunger having a front end inserted in the barrel with a gasket being attached to the front end, and a nozzle that is provided with a spraying hole for spraying the liquid medicine and that is connected to a front end of the barrel; a vial adapter having a transfer needle to pierce a vial that stores a liquid medicine so as to suction the liquid medicine; and a connection adapter that is attached to the syringe-shaped spraying device main body and that connects the vial adapter to the syringe-shaped spraying device main body.